2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain

Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., Waku, K.·1995·Biochemical and Biophysical Research Communications

Cited by (1,009)

Items 601–700 of 1,009

  1. Crucial Roles of the Endocannabinoid 2-Arachidonoylglycerol in the Suppression of Epileptic Seizures
    Yuki Sugaya, Maya Yamazaki, Motokazu Uchigashima, Kenta Kobayashi, Masahiko Watanabe, Kenji Sakimura, Masanobu Kano · 2016 · Cell Reports
  2. Ethanol, Endocannabinoids, and the Cannabinoidergic Signaling System
    Basalingappa L. Hungund, Balapal S. Basavarajappa, Csaba Vadász, George Kunos, Fernando Rodrı́guez de Fonseca, Giancarlo Colombo, Salvatore Serra, Loren H. Parsons, George F. Koob · 2002 · Alcoholism Clinical and Experimental Research
  3. Formation of N-Acyl-phosphatidylethanolamines and N-Acylethanolamines
    Harald Severin Hansen, Lotte Lauritzen, Birthe Moesgaard, Anne Mette Strand, Henrik H Hansen · 1998 · Biochemical Pharmacology
  4. Design, Synthesis, and Biological Evaluation of New Inhibitors of the Endocannabinoid Uptake: Comparison with Effects on Fatty Acid Amidohydrolase
    María Luz López-Rodríguez, Alma Viso, Silvia Ortega‐Gutiérrez, Christopher John Fowler, Gunnar Tiger, Eva de Lago, Javier Fernández‐Ruíz, José Antonio Ramos · 2003 · Journal of Medicinal Chemistry
  5. Endocannabinoids at the synapse a decade after the <i>dies mirabilis</i> (29 March 2001): what we still do not know
    Alger, Bradley E. · 2012 · The Journal of Physiology
  6. Endocannabinoids in the gastrointestinal tract
    Yunna Lee, Jeongbin Jo, Hae Young Chung, Charalabos Pothoulakis, Eunok Im · 2016 · American Journal of Physiology-Gastrointestinal and Liver Physiology
  7. DAGL‐dependent endocannabinoid signalling: roles in axonal pathfinding, synaptic plasticity and adult neurogenesis
    Madeleine J. Oudin, Carl Hobbs, Patrick Doherty · 2011 · European Journal of Neuroscience
  8. The dual blocker of FAAH/TRPV1 N-arachidonoylserotonin reverses the behavioral despair induced by stress in rats and modulates the HPA-axis
    Andrea Navarria, Alessandra Tamburella, Fabio Arturo Iannotti, Vincenzo Micale, Giovanni Camillieri, Lucia Gozzo, Roberta Verde, Roberta Imperatore, Gian Marco Leggio, Filippo Drago et al. · 2014 · Pharmacological Research
  9. Metabolism of anandamide and 2‐arachidonoylglycerol: An historical overview and some recent developments
    Vincenzo Di Marzo, Luciano De PETROCELLIS, Tiziana Bisogno, Dominique J. Melck · 1999 · Lipids
  10. Emerging drugs in neuropathic pain
    Ian Gilron, Terence J. Coderre · 2007 · Expert Opinion on Emerging Drugs
  11. The endocannabinoid hydrolysis inhibitor SA-57: intrinsic antinociceptive effects, augmented morphine-induced antinociception, and attenuated heroin seeking behavior in mice
    Wilkerson, Jenny L., Ghosh, Sudeshna, Mustafa, Mohammed, Abdullah, Rehab A., Niphakis, Micah J., Cabrera, Roberto, Maldonado, Rafael L., Cravatt, Benjamin F., Lichtman, Aron H. · 2017 · Neuropharmacology
  12. Cannabinoids and emotionality: a neuroanatomical perspective
    Ryan J. McLaughlin, Gabriella Gobbi · 2011 · Neuroscience
  13. Marijuana, endocannabinoids, and epilepsy: potential and challenges for improved therapeutic intervention
    Mackenzie E. Hofmann, C. Frazier · 2011 · Experimental Neurology
  14. The Phylogenetic Distribution and Evolutionary Origins of Endocannabinoid Signalling
    Maurice R. Elphick, Michaela Egertová · 2005 · Springer eBooks
  15. Fatty acid amide hydrolase localization in the human central nervous system: an immunohistochemical study
    Julián Romero, Cecilia J. Hillard, Miguel Calero, Alberto Rábano · 2002 · Molecular Brain Research
  16. The endocannabinoid system in the brain of Carassius auratus and its possible role in the control of food intake
    Marta Valenti, Erika Cottone, R. Martinez · 2005 · Journal of Neurochemistry
  17. Neurobehavioral activity in mice of N-vanillyl-arachidonyl-amide
    Vincenzo Di Marzo, Christopher S. Breivogel, Tiziana Bisogno, Dominique J. Melck, G. Patrick, Qing Tao, ARPAD SZALLASI, Raj K. Razdan, Billy R. Martin · 2000 · European Journal of Pharmacology
  18. Endocannabinoid hydrolases
    Natsuo Ueda · 2002 · Prostaglandins & Other Lipid Mediators
  19. TRP Channels as Novel Targets for Endogenous Ligands: Focus on Endocannabinoids and Nociceptive Signalling
    Maksim Storozhuk, Alexander V. Zholos · 2017 · Current Neuropharmacology
  20. Spinal Cord Stimulation and Treatment of Peripheral or Central Neuropathic Pain: Mechanisms and Clinical Application
    Liting Sun, Changgeng Peng, Elbert A.J. Joosten · 2021 · Neural Plasticity
  21. The actions and metabolism of lysophosphatidylinositol, an endogenous agonist for GPR55
    Atsushi Yamashita, Saori Oka, Takashi Tanikawa, Yasuhiro Hayashi, Yoko Nemoto‐Sasaki, Takayuki Sugiura · 2013 · Prostaglandins & Other Lipid Mediators
  22. Endocannabinoids at the spinal level regulate, but do not mediate, nonopioid stress-induced analgesia
    Richard L. Suplita, Tannia Gutierrez, Darren Fegley, Daniele Piomelli, Andrea G. Hohmann · 2005 · Neuropharmacology
  23. The endocannabinoid system in the inflammatory and neurodegenerative processes of multiple sclerosis and of amyotrophic lateral sclerosis.
    S. Rossi, G. Bernardi, D. Centonze · 2010 · Experimental Neurology
  24. Identification of Novel Endogenous Cytochrome P450 Arachidonate Metabolites with High Affinity for Cannabinoid Receptors
    Jian‐Kang Chen, Jianchun Chen, John D. Imig, Shouzuo D. Wei, David L. Hachey, Jagadeesh Setti Guthi, John Russell Falck, Jorge H. Capdevila, Raymond Clement Harris · 2008 · Journal of Biological Chemistry
  25. Interactions between endocannabinoids and stress-induced decreased sensitivity to natural reward
    David J. Rademacher, Cecilia J. Hillard · 2006 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  26. Activation of Type 5 Metabotropic Glutamate Receptors and Diacylglycerol Lipase- Initiates 2-Arachidonoylglycerol Formation and Endocannabinoid-Mediated Analgesia
    Laura C. Gregg, Kwang‐Mook Jung, Jessica Marie Spradley, Rita Nyilas, Richard L. Suplita, Angela Zimmer, Masahiko Watanabe, Ken Mackie, István Katona, Daniele Piomelli et al. · 2012 · Journal of Neuroscience
  27. Role of the Endocannabinoid System in the Pathophysiology of Schizophrenia
    Marc Fakhoury · 2016 · Molecular Neurobiology
  28. Endocannabinoids and food consumption: comparisons with benzodiazepine and opioid palatability-dependent appetite
    Steven J. Cooper · 2004 · European Journal of Pharmacology
  29. Monoacylglycerol Lipase Inhibitors Reverse Paclitaxel-Induced Nociceptive Behavior and Proinflammatory Markers in a Mouse Model of Chemotherapy-Induced Neuropathy
    Zachary A. Curry, Jenny L. Wilkerson, Deniz Bağdaş, S. Lauren Kyte, Nipa H. Patel, Giulia Donvito, Mohammed Ahmed Mustafa, Justin L. Poklis, Micah J. Niphakis, Ku‐Lung Hsu et al. · 2018 · Journal of Pharmacology and Experimental Therapeutics
  30. Cannabinoid CB1 receptor deficiency increases contextual fear memory under highly aversive conditions and long-term potentiation in vivo
    W. Jacob, Rudolph Marsch, Giovanni Marsicano, Beat Lutz, Carsten Tobias Wotjak · 2012 · Neurobiology of Learning and Memory
  31. CaMKII regulates diacylglycerol lipase-α and striatal endocannabinoid signaling
    Brian C. Shonesy, Xiaohan Wang, Kristie Lindsay Rose, Teniel S Ramikie, Victoria S. Cavener, Tyler J. Rentz, Anthony J. Baucum, Nidhi Jalan‐Sakrikar, Ken Mackie, Danny G. Winder et al. · 2013 · Nature Neuroscience
  32. Keep off the grass: marijuana use and acute cardiovascular events
    David G. E. Caldicott, James F. Holmes, Kurt C. Roberts‐Thomson · 2005 · European Journal of Emergency Medicine
  33. Discovery of endocannabinoids and some random thoughts on their possible roles in neuroprotection and aggression
    Raphael Mechoulam · 2002 · Prostaglandins Leukotrienes and Essential Fatty Acids
  34. Role of bioactive lipid mediators in obese adipose tissue inflammation and endocrine dysfunction
    Aritz Lopategi, Cristina López‐Vicario, José Alcaraz‐Quiles, Verónica García‐Alonso, Bibiana Rius, Esther Titos, Joan Clària · 2015 · Molecular and Cellular Endocrinology
  35. Understanding Metabolic Homeostasis and Imbalance: What Is the Role of the Endocannabinoid System?
    George Kunos · 2007 · The American Journal of Medicine
  36. Mouse and rat ultrasonic vocalizations in neuroscience and neuropharmacology: State of the art and future applications
    Marika Premoli, Susanna Pietropaolo, Markus Wöhr, Nicola Simola, Sara Anna Bonini · 2023 · European Journal of Neuroscience
  37. Involvement of the endogenous cannabinoid system in the effects of alcohol in the mesolimbic reward circuit: electrophysiological evidence in vivo
    Simona Perra, Giuliano Pillolla, Miriam Melis, Anna Lisa Muntoni, Gian Luigi Gessa, Marco Pistis · 2005 · Psychopharmacology
  38. The endocannabinoid system: directing eating behavior and macronutrient metabolism
    Bruce A. Watkins, Jeffrey J. Kim · 2015 · Frontiers in Psychology
  39. Development of a potent inhibitor of 2-arachidonoylglycerol hydrolysis with antinociceptive activity in vivo
    Tiziana Bisogno, Giorgio Ortar, Stefania Petrosino, Enrico Morera, Enza Palazzo, Marianna Nalli, Sabatino Maione, Vincenzo Di Marzo · 2008 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
  40. Brain Innate Immunity in the Regulation of Neuroinflammation: Therapeutic Strategies by Modulating CD200-CD200R Interaction Involve the Cannabinoid System
    Míriam Hernangómez, Francisco Javier Carrillo-Salinas, Míriam Mecha, Fernando Correa, Leyre Mestre, Frida Loría, Ana Feliú, Fabián Docagne, Carmen Guaza · 2014 · Current Pharmaceutical Design
  41. Beyond the CB1 Receptor: Is Cannabidiol the Answer for Disorders of Motivation?
    Natalie E. Zlebnik, Joseph F. Cheer · 2016 · Annual Review of Neuroscience
  42. A sensitive endocannabinoid assay. The simultaneous analysis of N-acylethanolamines and 2-monoacylglycerols
    Patricia C. Schmid, Keith D. Schwartz, Candice N. Smith · 2000 · Chemistry and Physics of Lipids
  43. The endocannabinoid signaling system: Pharmacological and therapeutic aspects
    Christopher John Fowler, Sandra Holt, Ove R Nilsson, Kent‐Olov Jonsson, Gunnar Tiger, Stig O. P. Jacobsson · 2005 · Pharmacology Biochemistry and Behavior
  44. The Potent Emetogenic Effects of the Endocannabinoid, 2-AG (2-Arachidonoylglycerol) Are Blocked by Δ9-Tetrahydrocannabinol and Other Cannnabinoids
    Nissar A. Darmani · 2002 · Journal of Pharmacology and Experimental Therapeutics
  45. Increasing 2-arachidonoyl glycerol signaling in the periphery attenuates mechanical hyperalgesia in a model of bone cancer pain
    Iryna A. Khasabova, Anisha Chandiramani, Catherine Harding-Rose, Donald A. Simone, Virginia S. Seybold · 2011 · Pharmacological Research
  46. Loss of Cannabinoid Receptor CB1 Induces Preterm Birth
    Haibin Wang, Huirong Xie, Sudhansu K. Dey · 2008 · PLoS ONE
  47. Acute and Non-acute Effects of Cannabis on Human Memory Function: A Critical Review of Neuroimaging Studies
    Matthijs Geert Bossong, Gerry Jager, Sagnik Bhattacharyya, Paul Allen · 2014 · Current Pharmaceutical Design
  48. Peripheral selectivity of the novel cannabinoid receptor antagonist TM 38837 in healthy subjects
    Linda E. Klumpers, Marianne Fridberg, Marieke L. de Kam, Paul B. Little, Niels Ole Jensen, Hendrik D. Kleinloog, Christian Elling, Joop van Gerven · 2013 · British Journal of Clinical Pharmacology
  49. The endocannabinoid system and Post Traumatic Stress Disorder (PTSD): From preclinical findings to innovative therapeutic approaches in clinical settings
    Andrea Berardi, Gustav Schelling, Patrizia Campolongo · 2016 · Pharmacological Research
  50. Endocannabinoids: Effectors of glucocorticoid signaling
    Georgia Balsevich, Gavin N. Petrie, Matthew N. Hill · 2017 · Frontiers in Neuroendocrinology
  51. Cannabinoid interventions for PTSD: Where to next?
    Luke John Ney, Allison Jane Matthews, Raimondo Bruno, Kim Louise Felmingham · 2019 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  52. Biosynthesis and inactivation of endocannabinoids: Relevance to their proposed role as neuromodulators
    Vincenzo Di Marzo · 1999 · Life Sciences
  53. Molecular probes for the cannabinoid receptors
    Atmaram D. Khanolkar, Sonya L. Palmer, Alexandros Makriyannis · 2000 · Chemistry and Physics of Lipids
  54. Plant-derived, synthetic and endogenous cannabinoids as neuroprotective agents
    Christopher John Fowler · 2003 · Brain Research Reviews
  55. Cannabis and Endocannabinoid Signaling in Epilepsy
    István Katona · 2015 · Handbook of experimental pharmacology
  56. The evolving science of phytocannabinoids
    Tristan A. Reekie, Michael Scott, Michael Kassiou · 2017 · Nature Reviews Chemistry
  57. Endocannabinoid-Based Therapies
    Daniele Piomelli, Alex Mabou Tagne · 2021 · The Annual Review of Pharmacology and Toxicology
  58. Differential effects of the antidepressants tranylcypromine and fluoxetine on limbic cannabinoid receptor binding and endocannabinoid contents
    Hill, Matthew N., Ho, Wing-Sze Vanessa, Hillard, Cecilia J., Gorzalka, Boris B. · 2008 · Journal of Neural Transmission
  59. Activation of CB1 cannabinoid receptors in the dorsolateral periaqueductal gray reduces the expression of contextual fear conditioning in rats
    Leonardo B.M. Resstel, Sabrina Francesca de Souza Lisboa, Daniele Cristina de Aguiar, Fernando Morgan de Aguiar Corrêa, Francisco Silveira Guimarães · 2008 · Psychopharmacology
  60. Updates in Reproduction Coming from the Endocannabinoid System
    Rosaria Meccariello, Natalia Battista, Heather B. Bradshaw, Haibin Wang · 2014 · International Journal of Endocrinology
  61. CB1 Cannabinoid Receptors Couple to Focal Adhesion Kinase to Control Insulin Release
    Katarzyna Maleńczyk, Magdalena Jazurek, Erik Keimpema, Cristoforo Silvestri, Justyna Janikiewicz, Ken Mackie, Vincenzo Di Marzo, Maria Jolanta Rędowicz, Tibor Harkany, Agnieszka Dobrzyń · 2013 · Journal of Biological Chemistry
  62. 2-Arachidonoylglycerol Modulation of Anxiety and Stress Adaptation: From Grass Roots to Novel Therapeutics
    Gaurav Bedse, Mathew N. Hill, Sachin Patel · 2020 · Biological Psychiatry
  63. Inhibiting degradation of 2-arachidonoylglycerol as a therapeutic strategy for neurodegenerative diseases
    Chu Chen · 2023 · Pharmacology & Therapeutics
  64. γ-Amino butyric acid and glutamate abnormalities in adolescent chronic marijuana smokers
    Andrew P. Prescot, Perry Franklin Renshaw, Deborah A Yurgelun-Todd · 2013 · Drug and Alcohol Dependence
  65. “Redundancy” of Endocannabinoid Inactivation: New Challenges and Opportunities for Pain Control
    Fabiana Piscitelli, Vincenzo Di Marzo · 2012 · ACS Chemical Neuroscience
  66. Endogenous cannabinoids: Metabolism and their role in reproduction
    Osama M. H. Habayeb, Stephen C. Bell, Justin C. Konje · 2002 · Life Sciences
  67. Proteins regulating the biosynthesis and inactivation of neuromodulatory fatty acid amides
    Matthew P. Patricelli, Benjamin F Cravatt · 2001 · Vitamins and hormones
  68. Cannabinoid modulation of drug reward and the implications of marijuana legalization
    Dan P. Covey, Jennifer M. Wenzel, Joseph F. Cheer · 2014 · Brain Research
  69. The emerging role of the endocannabinoid system in the pathogenesis and treatment of kidney diseases
    Joseph Tam · 2015 · Journal of Basic and Clinical Physiology and Pharmacology
  70. Neurotransmission systems in Parkinson’s disease
    Hossein Sanjari Moghaddam, Ameneh Zare-Shahabadi, Farzaneh Rahmani, Nima Rezaei · 2017 · Reviews in the Neurosciences
  71. Modulation of the Endocannabinoid System as a Potential Anticancer Strategy
    Robert Ramer, Rico Schwarz, Burkhard Hinz · 2019 · Frontiers in Pharmacology
  72. Putative neuroprotective actions of N-acyl-ethanolamines
    Harald Severin Hansen, Birthe Moesgaard, Gitte Lindved Petersen, Henrik H. Hansen · 2002 · Pharmacology & Therapeutics
  73. Binding affinity and agonist activity of putative endogenous cannabinoids at the human neocortical CB1 receptor
    Marc Steffens, Josef Zentner, Jürgen Bernd Honegger, Thomas J. Feuerstein · 2004 · Biochemical Pharmacology
  74. A novel fluorophosphonate inhibitor of the biosynthesis of the endocannabinoid 2‐arachidonoylglycerol with potential anti‐obesity effects
    Tiziana Bisogno, Anu Mahadevan, Roberto Coccurello, Jae Won Chang, Marco Allarà, Yugang Chen, Giacomo Giacovazzo, Aron H. Lichtman, Benjamin F. Cravatt, Anna Moles et al. · 2012 · British Journal of Pharmacology
  75. Endocannabinoids and their actions
    Mauro Maccarrone, Alessandro Finazzi‐Agrò · 2002 · Vitamins and hormones
  76. Design, Synthesis, and Biological Evaluation of New 1,8-Naphthyridin-4(1H)-on-3-carboxamide and Quinolin-4(1H)-on-3-carboxamide Derivatives as CB2Selective Agonists
    Clementina Manera, Veronica Benetti, M. Paola Castelli, Tiziana Cavallini, Sara Lazzarotti, Fabio Pibiri, Giuseppe Saccomanni, Tiziano Tuccinardi, Alfredo Vannacci, Adriano Martinelli et al. · 2006 · Journal of Medicinal Chemistry
  77. Targeting the cannabinoid CB2 receptor: modelling and structural determinants of CB2 selective ligands
    Antti Poso, John W. Huffman · 2007 · British Journal of Pharmacology
  78. Enhancement of endocannabinoid signaling and the pharmacotherapy of depression
    Regina A. Mangieri, Daniele Piomelli · 2007 · Pharmacological Research
  79. The influence of cannabinoids on learning and memory processes of the dorsal striatum
    Jarid Goodman, Mark G. Packard · 2015 · Neurobiology of Learning and Memory
  80. Novel Cannabinol Probes for CB1 and CB2 Cannabinoid Receptors
    Anu Mahadevan, Craig Siegel, Billy R. Martin · 2000 · Journal of Medicinal Chemistry
  81. Cell signaling by endocannabinoids and their congeners: questions of selectivity and other challenges
    Harald H.O. Schmid, Patricia C. Schmid, Evgueni V. Berdyshev · 2002 · Chemistry and Physics of Lipids
  82. Design, Synthesis and Biological Evaluation of Novel Arachidonic Acid Derivatives as Highly Potent and Selective Endocannabinoid Transporter Inhibitors
    María Luz López-Rodríguez, Alma Viso, Silvia Ortega‐Gutiérrez, Isabel Lastres‐Becker, Sara Rodrigo González, Javier Fernández‐Ruíz, José Antonio Ramos · 2001 · Journal of Medicinal Chemistry
  83. Systematic review of the literature on clinical and experimental trials on the antitumor effects of cannabinoids in gliomas
    Francisco Carlos Machado Rocha, Jair Guilherme Santos-Junior, Sérgio Carlos Stefano, Dartiu Xavier da Silveira · 2013 · Journal of Neuro-Oncology
  84. Neuronal populations mediating the effects of endocannabinoids on stress and emotionality
    Martin Häring, Stephan Guggenhuber, Beat Lutz · 2012 · Neuroscience
  85. Endocannabinoid Signaling Dynamics Probed with Optical Tools
    Thomas Heinbockel, Darrin H. Brager, Christian G. Reich, Jun Zhao, Sukumaran Muralidharan, Bradley E. Alger, Joseph P. Y. Kao · 2005 · Journal of Neuroscience
  86. Generation of lysophosphatidylinositol by DDHD domain containing 1 (DDHD1): Possible involvement of phospholipase D/phosphatidic acid in the activation of DDHD1
    Atsushi Yamashita, 熊澤 司紗, Hiroki Koga, Naotaka Suzuki, Saori Oka, Takayuki Sugiura · 2010 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
  87. Training-Associated Emotional Arousal Shapes Endocannabinoid Modulation of Spatial Memory Retrieval in Rats
    Maria Morena, Valentina De Castro, J. Megan Gray, Maura Palmery, Viviana Trezza, Benno Roozendaal, Matthew N. Hill, Patrizia Campolongo · 2015 · Journal of Neuroscience
  88. Hypothesis: cannabinoid therapy for the treatment of gliomas?
    Guillermo Velasco, Ismael Galve‐Roperh, Cristina Sánchez, Cristina Blázquez, Manuel Guzmán · 2004 · Neuropharmacology
  89. Towards cannabinoid drugs – revisited
    Raphael Mechoulam, Lumir Ondrej Hanus, Ester Fride · 1998 · Progress in medicinal chemistry
  90. Impaired endocannabinoid signalling in the rostral ventromedial medulla underpins genotype-dependent hyper-responsivity to noxious stimuli
    Kieran Rea, Weredeselam M. Olango, Bright N. Okine, Manish K. Madasu, Iseult C. McGuire, Kathleen Coyle, Brendan Harhen, Michelle Roche, David P. Finn · 2013 · Pain
  91. The anticonvulsant effects of cannabidiol in experimental models of epileptic seizures: From behavior and mechanisms to clinical insights
    Willian Lazarini-Lopes, Raquel A. Do Val-da Silva, Rui Milton Patrício da Silva-Júnior, João Pereira Leite, Norberto Garcia‐Cairasco · 2020 · Neuroscience & Biobehavioral Reviews
  92. Development of a 3D Model for the Human Cannabinoid CB1 Receptor
    Outi M. H. Salo‐Ahen, Maija K. Lahtela-Kakkonen, Jukka Gynther · 2004 · Journal of Medicinal Chemistry
  93. BDNF regulates neuronal sensitivity to endocannabinoids
    Patrick Maison, Deborah J. Walker, Frank S. Walsh, Gareth Haydn Williams, Patrick Doherty · 2009 · Neuroscience Letters
  94. Epigenetic Regulation of Immunological Alterations Following Prenatal Exposure to Marijuana Cannabinoids and its Long Term Consequences in Offspring
    Elizabeth E. Zumbrun, Jessica Margaret Sido, Prakash S. Nagarkatti, Mitzi Nagarkatti · 2015 · Journal of Neuroimmune Pharmacology
  95. Complementary synaptic distribution of enzymes responsible for synthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in the human hippocampus
    Anikó Ludányi, Sherry Shu‐Jung Hu, Maya Yamazaki, Asami Tanimura, Daniele Piomelli, Masahiko Watanabe, Masanobu Kano, Kenji Sakimura, Zsófia Maglóczky, Ken Mackie et al. · 2010 · Neuroscience
  96. Endocannabinoids suppress excitatory synaptic transmission to dorsal raphe serotonin neurons through the activation of presynaptic CB1 receptors.
    Haj-Dahmane, Samir, Shen, Roh-Yu · 2009 · The Journal of Pharmacology and Experimental Therapeutics
  97. The Selective Monoacylglycerol Lipase Inhibitor MJN110 Produces Opioid-Sparing Effects in a Mouse Neuropathic Pain Model
    Jenny L. Wilkerson, Micah J. Niphakis, Travis W. Grim, Mohammed A. Mustafa, Rehab A. Abdullah, Justin L. Poklis, William L. Dewey, Hamid I. Akbarali, Matthew L. Banks, Laura E. Wise et al. · 2016 · Journal of Pharmacology and Experimental Therapeutics
  98. Designing microorganisms for heterologous biosynthesis of cannabinoids
    Ângela Carvalho, Esben Halkjær Hansen, Oliver Kayser, Simon Carlsen, Felix Stehle · 2017 · FEMS Yeast Research
  99. The role of endocannabinoids in the hypothalamic regulation of visceral function
    T. Wenger, Gabriella Moldrich · 2002 · Prostaglandins Leukotrienes and Essential Fatty Acids
  100. Inhibition by 2-Arachidonoylglycerol, a Novel Type of Possible Neuromodulator, of the Depolarization-Induced Increase in Intracellular Free Calcium in Neuroblastoma × Glioma Hybrid NG108-15 Cells
    Takayuki Sugiura, Tomoko Kodaka, Sachiko Kondo · 1997 · Biochemical and Biophysical Research Communications